Cargando…

Targeting the tumor vasculature with engineered cystine-knot miniproteins

The extra domain B splice variant (EDB) of human fibronectin selectively expressed in the tumor vasculature is an attractive target for cancer imaging and therapy. Here, we describe the generation and characterization of EDB-specific optical imaging probes. By screening combinatorial cystine-knot mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lui, Bonny Gaby, Salomon, Nadja, Wüstehube-Lausch, Joycelyn, Daneschdar, Matin, Schmoldt, Hans-Ulrich, Türeci, Özlem, Sahin, Ugur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962393/
https://www.ncbi.nlm.nih.gov/pubmed/31941901
http://dx.doi.org/10.1038/s41467-019-13948-y
_version_ 1783488156701556736
author Lui, Bonny Gaby
Salomon, Nadja
Wüstehube-Lausch, Joycelyn
Daneschdar, Matin
Schmoldt, Hans-Ulrich
Türeci, Özlem
Sahin, Ugur
author_facet Lui, Bonny Gaby
Salomon, Nadja
Wüstehube-Lausch, Joycelyn
Daneschdar, Matin
Schmoldt, Hans-Ulrich
Türeci, Özlem
Sahin, Ugur
author_sort Lui, Bonny Gaby
collection PubMed
description The extra domain B splice variant (EDB) of human fibronectin selectively expressed in the tumor vasculature is an attractive target for cancer imaging and therapy. Here, we describe the generation and characterization of EDB-specific optical imaging probes. By screening combinatorial cystine-knot miniprotein libraries with phage display technology we discover exquisitely EDB-specific ligands that share a distinctive motif. Probes with a binding constant in the picomolar range are generated by chemical oligomerization of selected ligands and fluorophore conjugation. We show by fluorescence imaging that the probes stain EDB in tissue sections derived from human U-87 MG glioblastoma xenografts in mice. Moreover, we demonstrate selective accumulation and retention of intravenously administered probes in the tumor tissue of mice with U-87 MG glioblastoma xenografts by in vivo and ex vivo fluorescence imaging. These data warrants further pursuit of the selected cystine-knot miniproteins for in vivo imaging applications.
format Online
Article
Text
id pubmed-6962393
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-69623932020-01-17 Targeting the tumor vasculature with engineered cystine-knot miniproteins Lui, Bonny Gaby Salomon, Nadja Wüstehube-Lausch, Joycelyn Daneschdar, Matin Schmoldt, Hans-Ulrich Türeci, Özlem Sahin, Ugur Nat Commun Article The extra domain B splice variant (EDB) of human fibronectin selectively expressed in the tumor vasculature is an attractive target for cancer imaging and therapy. Here, we describe the generation and characterization of EDB-specific optical imaging probes. By screening combinatorial cystine-knot miniprotein libraries with phage display technology we discover exquisitely EDB-specific ligands that share a distinctive motif. Probes with a binding constant in the picomolar range are generated by chemical oligomerization of selected ligands and fluorophore conjugation. We show by fluorescence imaging that the probes stain EDB in tissue sections derived from human U-87 MG glioblastoma xenografts in mice. Moreover, we demonstrate selective accumulation and retention of intravenously administered probes in the tumor tissue of mice with U-87 MG glioblastoma xenografts by in vivo and ex vivo fluorescence imaging. These data warrants further pursuit of the selected cystine-knot miniproteins for in vivo imaging applications. Nature Publishing Group UK 2020-01-15 /pmc/articles/PMC6962393/ /pubmed/31941901 http://dx.doi.org/10.1038/s41467-019-13948-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Lui, Bonny Gaby
Salomon, Nadja
Wüstehube-Lausch, Joycelyn
Daneschdar, Matin
Schmoldt, Hans-Ulrich
Türeci, Özlem
Sahin, Ugur
Targeting the tumor vasculature with engineered cystine-knot miniproteins
title Targeting the tumor vasculature with engineered cystine-knot miniproteins
title_full Targeting the tumor vasculature with engineered cystine-knot miniproteins
title_fullStr Targeting the tumor vasculature with engineered cystine-knot miniproteins
title_full_unstemmed Targeting the tumor vasculature with engineered cystine-knot miniproteins
title_short Targeting the tumor vasculature with engineered cystine-knot miniproteins
title_sort targeting the tumor vasculature with engineered cystine-knot miniproteins
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962393/
https://www.ncbi.nlm.nih.gov/pubmed/31941901
http://dx.doi.org/10.1038/s41467-019-13948-y
work_keys_str_mv AT luibonnygaby targetingthetumorvasculaturewithengineeredcystineknotminiproteins
AT salomonnadja targetingthetumorvasculaturewithengineeredcystineknotminiproteins
AT wustehubelauschjoycelyn targetingthetumorvasculaturewithengineeredcystineknotminiproteins
AT daneschdarmatin targetingthetumorvasculaturewithengineeredcystineknotminiproteins
AT schmoldthansulrich targetingthetumorvasculaturewithengineeredcystineknotminiproteins
AT tureciozlem targetingthetumorvasculaturewithengineeredcystineknotminiproteins
AT sahinugur targetingthetumorvasculaturewithengineeredcystineknotminiproteins